Cargando…

Risperidone and Levothyroxine for Managing “Myxedema Madness”

Hypothyroidism is one of the common comorbidities seen in patients with psychiatric conditions. Sometimes few patients may present with neuropsychiatric symptoms such as cognitive slowing, depression, or psychosis (“myxedema madness”). These patients are managed with antipsychotic medications while...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Rikinkumar S, Heer, Arpit S, Lesko, Aquila, Kim, Sung W, Ishaq, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526983/
https://www.ncbi.nlm.nih.gov/pubmed/33014650
http://dx.doi.org/10.7759/cureus.10152
_version_ 1783588960744767488
author Patel, Rikinkumar S
Heer, Arpit S
Lesko, Aquila
Kim, Sung W
Ishaq, Muhammad
author_facet Patel, Rikinkumar S
Heer, Arpit S
Lesko, Aquila
Kim, Sung W
Ishaq, Muhammad
author_sort Patel, Rikinkumar S
collection PubMed
description Hypothyroidism is one of the common comorbidities seen in patients with psychiatric conditions. Sometimes few patients may present with neuropsychiatric symptoms such as cognitive slowing, depression, or psychosis (“myxedema madness”). These patients are managed with antipsychotic medications while admitting laboratory works are processed. It has been found that antipsychotic use is associated with lower free thyroxine levels, so untreated hypothyroid patients may experience worsening of symptoms with antipsychotic use. It is recommended that hypothyroid patients with psychosis be treated for the underlying hypothyroidism with thyroid hormone replacement. In this article, we are presenting a case of a hypothyroid patient presenting to a psychiatric facility for worsening psychosis and persecutory delusions, and medication non-compliance to levothyroxine. We also discuss the management of psychosis in a patient with worsening hypothyroidism with a combination regimen: levothyroxine and risperidone.
format Online
Article
Text
id pubmed-7526983
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-75269832020-10-01 Risperidone and Levothyroxine for Managing “Myxedema Madness” Patel, Rikinkumar S Heer, Arpit S Lesko, Aquila Kim, Sung W Ishaq, Muhammad Cureus Endocrinology/Diabetes/Metabolism Hypothyroidism is one of the common comorbidities seen in patients with psychiatric conditions. Sometimes few patients may present with neuropsychiatric symptoms such as cognitive slowing, depression, or psychosis (“myxedema madness”). These patients are managed with antipsychotic medications while admitting laboratory works are processed. It has been found that antipsychotic use is associated with lower free thyroxine levels, so untreated hypothyroid patients may experience worsening of symptoms with antipsychotic use. It is recommended that hypothyroid patients with psychosis be treated for the underlying hypothyroidism with thyroid hormone replacement. In this article, we are presenting a case of a hypothyroid patient presenting to a psychiatric facility for worsening psychosis and persecutory delusions, and medication non-compliance to levothyroxine. We also discuss the management of psychosis in a patient with worsening hypothyroidism with a combination regimen: levothyroxine and risperidone. Cureus 2020-08-31 /pmc/articles/PMC7526983/ /pubmed/33014650 http://dx.doi.org/10.7759/cureus.10152 Text en Copyright © 2020, Patel et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Patel, Rikinkumar S
Heer, Arpit S
Lesko, Aquila
Kim, Sung W
Ishaq, Muhammad
Risperidone and Levothyroxine for Managing “Myxedema Madness”
title Risperidone and Levothyroxine for Managing “Myxedema Madness”
title_full Risperidone and Levothyroxine for Managing “Myxedema Madness”
title_fullStr Risperidone and Levothyroxine for Managing “Myxedema Madness”
title_full_unstemmed Risperidone and Levothyroxine for Managing “Myxedema Madness”
title_short Risperidone and Levothyroxine for Managing “Myxedema Madness”
title_sort risperidone and levothyroxine for managing “myxedema madness”
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526983/
https://www.ncbi.nlm.nih.gov/pubmed/33014650
http://dx.doi.org/10.7759/cureus.10152
work_keys_str_mv AT patelrikinkumars risperidoneandlevothyroxineformanagingmyxedemamadness
AT heerarpits risperidoneandlevothyroxineformanagingmyxedemamadness
AT leskoaquila risperidoneandlevothyroxineformanagingmyxedemamadness
AT kimsungw risperidoneandlevothyroxineformanagingmyxedemamadness
AT ishaqmuhammad risperidoneandlevothyroxineformanagingmyxedemamadness